(Total Views: 732)
Posted On: 10/20/2025 2:50:38 AM
Post# of 158148
My wrote:
from Dr. Jay interview, Min. 21:30
I really hope you are right. That piece from the interview opens up the wonderful possibility that patients in the CRC trial will be able to get an ICI within the trial -- and be saved. The FDA should be able to understand that human lives are in their hands. A Yes saves those lives; a No may end many of them.
from Dr. Jay interview, Min. 21:30
Quote:
"And recently, we have collated all of our oncology data into a briefing book so that the folks at FDA can now understand what CytoDyn is trying to do. And as a result, it's opening options to us about how we can even further improve our CRC study. So I'm excited about that as well."
... the meeting is for FDA to understand what Cytodyn wants to do.
...1st keep it simplified to FDA in the Briefing Book. Then, they will say ok -- [and] modify CRC to include ICI asap if / when Upregulating optimum shows
I really hope you are right. That piece from the interview opens up the wonderful possibility that patients in the CRC trial will be able to get an ICI within the trial -- and be saved. The FDA should be able to understand that human lives are in their hands. A Yes saves those lives; a No may end many of them.
(15)
(0)
